# Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock

> **NCT07313670** · NA · NOT_YET_RECRUITING · sponsor: **Muhammad Aamir Latif** · enrollment: 122 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Intravenous Hydrocortisone
- **DRUG:** Standard care

## Key facts

- **NCT ID:** NCT07313670
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313670, "Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07313670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*